Effects of continued use of targeted therapy on patients with pulmonary arterial hypertension and complicated by hemoptysis.
作者信息
Wang Zhong-Chao, Han Xiu-Min, Zuo Yao, Dong Na, Wang Jian-Ming, Meng Li-Li, Xiao Jia-Wang, Zhao Ming, Mi Yuan, Wang Qi-Guang
机构信息
Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.
出版信息
J Geriatr Cardiol. 2025 Mar 28;22(3):404-410. doi: 10.26599/1671-5411.2025.03.005.
Abstract
摘要
相似文献
1
Effects of continued use of targeted therapy on patients with pulmonary arterial hypertension and complicated by hemoptysis.持续使用靶向治疗对合并咯血的肺动脉高压患者的影响。
J Geriatr Cardiol. 2025 Mar 28;22(3):404-410. doi: 10.26599/1671-5411.2025.03.005.
2
[Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].小儿特发性肺动脉高压的预后及相关危险因素分析
Zhonghua Er Ke Za Zhi. 2018 Jan 2;56(1):23-28. doi: 10.3760/cma.j.issn.0578-1310.2018.01.007.
3
Recurrent hemoptysis: an emerging life-threatening complication in idiopathic pulmonary arterial hypertension.复发性咯血：特发性肺动脉高压的一种新出现的危及生命的并发症。
Chest. 2011 Mar;139(3):690-693. doi: 10.1378/chest.10-1134.
4
Pulmonary mucormycosis: a case of pulmonary arterial hypertension, Westermark sign, and bronchopleural fistula.肺毛霉菌病：一例合并肺动脉高压、韦斯特马克征及支气管胸膜瘘的病例
J Int Med Res. 2020 Nov;48(11):300060520971450. doi: 10.1177/0300060520971450.
5
Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.儿童肺动脉高压中咯血的频率及预后意义。
Am J Cardiol. 2013 Nov 1;112(9):1505-9. doi: 10.1016/j.amjcard.2013.06.034. Epub 2013 Aug 22.
6
[Clinical evaluation and interventional therapy for chronic pulmonary aspergillosis complicated by hemoptysis].
Zhonghua Jie He He Hu Xi Za Zhi. 2025 May 12;48(5):405-407. doi: 10.3760/cma.j.cn112147-20250320-00157.
7
Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension.特发性和遗传性肺动脉高压咯血的危险因素。
PLoS One. 2013 Oct 23;8(10):e78132. doi: 10.1371/journal.pone.0078132. eCollection 2013.
8
Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study.慢性血栓栓塞性肺动脉高压咯血支气管动脉栓塞的疗效和安全性：一项前瞻性队列研究的初步结果。
Crit Care Med. 2019 Mar;47(3):e182-e189. doi: 10.1097/CCM.0000000000003578.
9
Bronchial artery embolization for pulmonary arterial hypertension and recurrent hemoptysis?支气管动脉栓塞术治疗肺动脉高压和反复咯血？
Am J Cardiol. 2008 Apr 1;101(7):1064-5. doi: 10.1016/j.amjcard.2007.11.062. Epub 2008 Feb 6.
10
Successful Pulmonary Artery Embolization for the Management of Hemoptysis in a Patient with Eisenmenger Syndrome Caused by Patent Ductus Arteriosus.成功进行肺动脉栓塞术治疗动脉导管未闭所致艾森曼格综合征患者的咯血
Intern Med. 2017 Dec 15;56(24):3299-3304. doi: 10.2169/internalmedicine.9071-17. Epub 2017 Oct 11.
本文引用的文献
1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
2
Bronchial artery embolization for hemoptysis: A systematic review and meta-analysis.咯血的支气管动脉栓塞术：一项系统评价与荟萃分析。
J Interv Med. 2021 Aug 13;4(4):172-180. doi: 10.1016/j.jimed.2021.08.003. eCollection 2021 Nov.
3
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.利奥西呱治疗慢性血栓栓塞性肺动脉高压患者：EXPERT 注册研究的最终安全性数据。
Respir Med. 2021 Mar;178:106220. doi: 10.1016/j.rmed.2020.106220. Epub 2020 Nov 12.
4
The ESC Clinical Practice Guidelines for the Management of Adult Congenital Heart Disease 2020.《2020年欧洲心脏病学会成人先天性心脏病管理临床实践指南》
Eur Heart J. 2020 Nov 14;41(43):4153-4154. doi: 10.1093/eurheartj/ehaa701.
5
Clinical characteristics and aetiological analysis of 133 patients for pulmonary embolism combined with haemoptysis.133例肺栓塞合并咯血患者的临床特征及病因分析
Clin Respir J. 2021 Feb;15(2):169-176. doi: 10.1111/crj.13281. Epub 2021 Jan 26.
6
A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.中国 2 家中心回顾性研究：血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂在高血压合并 COVID-19 患者中的持续使用效果。
Med Sci Monit. 2020 Sep 24;26:e926651. doi: 10.12659/MSM.926651.
7
Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study.慢性血栓栓塞性肺动脉高压咯血支气管动脉栓塞的疗效和安全性：一项前瞻性队列研究的初步结果。
Crit Care Med. 2019 Mar;47(3):e182-e189. doi: 10.1097/CCM.0000000000003578.
8
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会（ESC）/欧洲呼吸学会（ERS）肺动脉高压诊断和治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断和治疗联合工作组：得到以下组织认可：欧洲儿科和先天性心脏病协会（AEPC）、国际心肺移植学会（ISHLT）。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
9
ACR appropriateness criteria® hemoptysis.美国放射学会适宜性标准®咯血
J Thorac Imaging. 2014 May;29(3):W19-22. doi: 10.1097/RTI.0000000000000084.
10
Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.儿童肺动脉高压中咯血的频率及预后意义。
Am J Cardiol. 2013 Nov 1;112(9):1505-9. doi: 10.1016/j.amjcard.2013.06.034. Epub 2013 Aug 22.
Zotero 插件